title: Editorial Commentary: A Collaborative Model for Endpoint Development: Advancing the Science of Antibacterial Drug Clinical Trials.
authors.affiliation: Office of Antimicrobial Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Joseph G
authors.initials: JG
authors.lastname: Toerner
authors.affiliation: Office of Antimicrobial Products, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, Maryland.
authors.forename: Edward
authors.initials: E
authors.lastname: Cox
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003627:Data Interpretation, Statistical; D004341:Drug Evaluation; D023381:Endpoint Determination; D006801:Humans; D012107:Research Design
chemical_list: D000900:Anti-Bacterial Agents
keywords: antibacterial drug development; clinical endpoints; non-inferiority trial design